MWA
CO

Marshall Wace Asia’s Global Cord Blood Corporation CO Stock Holding History

Marshall Wace Asia’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-46,613
Closed -$165K – 196
2020
Q3 		$165K Buy
+46,613
New +$162K ﹤0.01% 127

Other funds holding CO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Marshall Wace Asia's CO Position: Q4 2020 in Review

Marshall Wace Asia sold out of Global Cord Blood Corporation (CO) in Q4 2020, closing a stake of 46,613 shares — an estimated $165K sold.

Marshall Wace Asia first reported a position in CO in Q3 2020 and held it in 1 quarter. The position peaked at $165K in Q3 2020. 28 funds tracked by Wall St. Rank hold CO as of Q4 2020.

  • Marshall Wace Asia reported no remaining Global Cord Blood Corporation position as of Q4 2020 after selling out during the quarter.
  • Marshall Wace Asia sold 46,613 Global Cord Blood Corporation shares in Q4 2020, an estimated $165K.
  • Marshall Wace Asia first reported a position in Global Cord Blood Corporation in Q3 2020 and held it in 1 quarter.
  • Marshall Wace Asia's Global Cord Blood Corporation position peaked at $165K in Q3 2020.
  • 28 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2020.

Based on Marshall Wace Asia's 13F filing for Q4 2020, filed 16 Feb 2021.